Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -24.2% | +2.5% | 2 / 3 | +0.5% | -0.90 pp | -0.04 pp | +1.5% | 3.54 | 17.70 | 435 | +0,5% | 0,6 | −24,2% | 17.70 | 24.15 | −26,7% |
| Pts | 0 | 0 | 8 | 0 | 4 | 4 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 2.800 (close price on 2026-10-19)EPS (TTM): 158,2
Financial charts
1.Revenue & growth
VND bn435Q2/26
1.Revenue & growth
VND bn435Q2/26
2.Profit & growth
VND bn0,77Q2/26
3.Profit mix (Penman)
VND bn7,18Q2/26
4.Margins & cost structure
%3.0%Q2/26
5.Returns & cash cycle
% · days1.9%Q2/26
6.Earnings quality & cash
VND bn-137Q2/26
7.Asset structure
VND bn2.224Q2/26
8.Funding & debt health
VND bn · times2.224Q2/26
9.Revenue backlog
VND bn440Q2/26
10.Valuation
times · %17,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %29Q2/26
Adjusted EPS growth, latest quarter
-2.0%
Average adjusted EPS growth, 3 quarters
9.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26